tradingkey.logo
tradingkey.logo
Pesquisar

Metagenomi Inc

MGX
Adicionar à lista de desejos
1.260USD
+0.050+4.13%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
47.44MValor de mercado
PerdaP/L TTM

Mais detalhes de Metagenomi Inc Empresa

Metagenomi, Inc. is a precision genetic medicine company. The Company is focused on developing curative therapeutics for patients using its comprehensive metagenomics derived toolbox. Its diverse and modular genome editing toolbox is designed to precisely target any site in the human genome. Its comprehensive genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs). It has also developed a modular toolbox of genome editing systems that will allow it to interact with the human genome in a site-specific manner, where each tool can be matched to specific disease targets. The Company uses artificial intelligence and its metagenomics platform to develop curative genetic medicines.

Informações de Metagenomi Inc

Código da empresaMGX
Nome da EmpresaMetagenomi Inc
Data de listagemFeb 09, 2024
CEOIrish (Jian)
Número de funcionários202
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 09
Endereço5959 Horton St
CidadeEMERYVILLE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94608
Telefone15108714880
Sitehttps://metagenomi.co/
Código da empresaMGX
Data de listagemFeb 09, 2024
CEOIrish (Jian)

Executivos da empresa Metagenomi Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Eric H. Bjerkholt
Mr. Eric H. Bjerkholt
Independent Director
Independent Director
--
--
,
,
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
Senior Vice President, Head of Legal, Compliance Officer and Corporate Secretary
--
--
Mr. Laurence E. Reid, Ph.D.
Mr. Laurence E. Reid, Ph.D.
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Brian C. Thomas, Ph.D.
Dr. Brian C. Thomas, Ph.D.
Co-Founder, Director
Co-Founder, Director
2.40M
+1.61%
Dr. Jian Irish, Ph.D.
Dr. Jian Irish, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
600.86K
-0.62%
Dr. Sarah B. Noonberg, M.D., Ph.D.
Dr. Sarah B. Noonberg, M.D., Ph.D.
Chief Medical Officer
Chief Medical Officer
109.14K
-4.80%
Dr. Juergen Eckhardt, M.D.
Dr. Juergen Eckhardt, M.D.
Independent Director
Independent Director
--
--
Dr. Willard H. Dere, M.D.
Dr. Willard H. Dere, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Pamela M. (Pam) Wapnick
Ms. Pamela M. (Pam) Wapnick
Chief Financial Officer
Chief Financial Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Metagenomi Inc?

Os cinco principais acionistas de Metagenomi Inc são: Dr. Brian C. Thomas, Ph.D.

Quantas instituições possuem ações da Metagenomi Inc (MGX)?

Em 2026Q1, 172 instituições possuíam ações da Metagenomi Inc, com valor de mercado aproximado de 8.82M, representando 23.43% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -6411264.00.